Mar 13, 2019
Final Month to Enter ChanceX12

Hurry, enrollment is closing for Mesivta Shaarei Adirim’s unique recurring raffle, ChanceX12, with a chance to win $10,000.


Hurry, enrollment is closing for Mesivta Shaarei Adirim’s unique recurring raffle, ChanceX12! After this month’s drawing, on Thursday, March 28th , no new entries will be accepted. Act fast!

If you grab your ticket before Thursday, March 28 th , that’s great! Each month, for 12 months from when you sign up, you’ll be entered into the raffle to win $10,000. That means, if you enter this month, you will be entered each month until March 2020!

Sign up today at!

This unique raffle is an initiative of Mesivta Shaarei Adirim, the Midwest affiliate of Mesivta Shaarei Arazim in Monsey. Under the leadership of Rabbi Mordechei Elbaum, Rabbi Avrohom Yitzchak Ausband, and Rabbi Shlomo Caplan, this unique Makom Torah empowers its talmidim to be successful–not just in the classroom, but at life. The yeshiva fosters growth and confidence while providing non-academic opportunities for success alongside the traditional curriculum, like acrobatics, wood-working, music, photography, and more.

Earlier this year, Mesivta Shaarei Adirim rolled out this unique raffle campaign to generate awareness and funding for the Yeshiva.
To recap, in a never-before-seen format, this raffle offers participants the opportunity to dip back into the lottery pot once a month for 12 months.

Participants commit to a $36 monthly donation and are entered into a raffle for 12 chances to win $10,000. Since participation is capped at 3,500 tickets, chances of winning come out to 1/292– great odds!

Since the first drawing in September, the winners’ circle has included: Steven Berkovitch, Aderet Blazer, Moshe Lavinski, Shloime Dachs, Yehuda Daiches, and Ari Sendic– and who knows–maybe this could be your lucky month!

Sign up today at!

Maaser money may be used towards ticket purchases for this raffle, as per Dayan Harav Shmuel Fuerst of Chicago, Illinois.

Most Read Most Comments

Opinions and Comments
No Comments Yet
What's Your Opinion? Post a Comment

Your Comment:

Comments must be approved before being published. Thank You!

Make COLive® your homepage | Contact Us
© 2019